Literature DB >> 20640553

Pro12Ala polymorphism in PPAR-gamma2 and dementia in Chinese nonagenarians/centenarians.

Ji-Rong Yue1, Bi-Rong Dong, Chang-Quan Huang, Zhen-Chan Lu, Hong-Mei Wu, Yan-Ling Zhang.   

Abstract

We examined the existence of a relationship between polymorphism and dementia in subjects aged 90 years and above. The sample included 732 unrelated Chinese nonagenarians/centenarians (aged 90-108 years, mean age 93.68 years; 67.5% women). The Pro12Ala variant was examined using polymerase chain reaction restriction fragment length polymorphism. Cognitive function was measured with 30-item mini-mental state examination. The genotype frequencies of the Pro12Ala polymorphism were 0% Ala12Ala, 9.1% Pro12Ala, and 90.9% Pro12Pro. The prevalence rates of dementia were 64.9% in the whole sample (45.0% for men and 74.5% for women). In both men and women, between subjects with and without 12Ala carriers, there was no significant difference in cognitive function scores and also no significant difference in prevalence of dementia; there was no significant difference in frequency of 12Ala carriers between subjects with and without dementia. Multiple logistic regression was performed by adjusting clinical factors that are thought to be associated with cognitive function or with 12Ala carriers. We found that 12Ala is not a risk factor for dementia. We found that Pro12Ala polymorphism in PPAR-gamma2 was not directly correlated with dementia among Chinese nonagenarians and centenarians.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640553      PMCID: PMC2926853          DOI: 10.1007/s11357-010-9132-1

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  27 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  The mini-mental state examination: a comprehensive review.

Authors:  T N Tombaugh; N J McIntyre
Journal:  J Am Geriatr Soc       Date:  1992-09       Impact factor: 5.562

3.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

4.  Content validity for dementia of three generic preference based health related quality of life instruments.

Authors:  Michel Silberfeld; Sergio Rueda; Murray Krahn; Gary Naglie
Journal:  Qual Life Res       Date:  2002-02       Impact factor: 4.147

5.  Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation.

Authors:  C J Yen; B A Beamer; C Negri; K Silver; K A Brown; D P Yarnall; D K Burns; J Roth; A R Shuldiner
Journal:  Biochem Biophys Res Commun       Date:  1997-12-18       Impact factor: 3.575

6.  Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.

Authors:  B M Forman; J Chen; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

7.  Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population.

Authors:  E Shyong Tai; Dolores Corella; Mabel Deurenberg-Yap; Xian Adiconis; Suok Kai Chew; Chee Eng Tan; Jose M Ordovas
Journal:  J Lipid Res       Date:  2004-01-16       Impact factor: 5.922

8.  A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

Authors:  S A Kliewer; J M Lenhard; T M Willson; I Patel; D C Morris; J M Lehmann
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

9.  Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study.

Authors:  J W Jama; L J Launer; J C Witteman; J H den Breeijen; M M Breteler; D E Grobbee; A Hofman
Journal:  Am J Epidemiol       Date:  1996-08-01       Impact factor: 4.897

10.  Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.

Authors:  P Tontonoz; E Hu; B M Spiegelman
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

View more
  5 in total

1.  Association of sleep quality and dementia among long-lived Chinese older adults.

Authors:  Yue Jirong; Huang Changquan; Wu Hongmei; Dong Bi-Rong
Journal:  Age (Dordr)       Date:  2012-06-06

2.  The PPARG Pro12Ala Polymorphism and 20-year Cognitive Decline: Race and Sex Heterogeneity.

Authors:  Nancy A West; Jonathan V Tingle; Jeannette Simino; Elizabeth Selvin; Jan Bressler; Thomas H Mosley
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Apr-Jun       Impact factor: 2.703

3.  G-395A polymorphism in the promoter region of the KLOTHO gene associates with reduced cognitive impairment among the oldest old.

Authors:  Qiukui Hao; Xiang Ding; Langli Gao; Ming Yang; Birong Dong
Journal:  Age (Dordr)       Date:  2016-01-05

4.  Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study.

Authors:  Nienke Legdeur; Maryam Badissi; Stephen F Carter; Sophie de Crom; Aleid van de Kreeke; Ralph Vreeswijk; Marijke C Trappenburg; Mardien L Oudega; Huiberdina L Koek; Jos P van Campen; Carolina J P W Keijsers; Chinenye Amadi; Rainer Hinz; Mark F Gordon; Gerald Novak; Jana Podhorna; Erik Serné; Frank Verbraak; Maqsood Yaqub; Arjan Hillebrand; Alessandra Griffa; Neil Pendleton; Sophia E Kramer; Charlotte E Teunissen; Adriaan Lammertsma; Frederik Barkhof; Bart N M van Berckel; Philip Scheltens; Majon Muller; Andrea B Maier; Karl Herholz; Pieter Jelle Visser
Journal:  BMC Geriatr       Date:  2018-11-26       Impact factor: 3.921

5.  The Klotho gene G-395A polymorphism and metabolic syndrome in very elderly people.

Authors:  Li Luo; Qiukui Hao; Birong Dong; Ming Yang
Journal:  BMC Geriatr       Date:  2016-02-15       Impact factor: 3.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.